tetano
Editor, Senior Moderator
Signal Transduct Target Ther
. 2023 Nov 1;8(1):416.
doi: 10.1038/s41392-023-01640-z. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li[SUP] #[/SUP][SUP] 1 [/SUP], Yun Zhou[SUP] #[/SUP][SUP] 1 [/SUP], Jiechao Ma[SUP] #[/SUP][SUP] 2 [/SUP], Qin Zhang[SUP] #[/SUP][SUP] 1 3 [/SUP], Jun Shao[SUP] 1 [/SUP], Shufan Liang[SUP] 1 [/SUP], Yizhou Yu[SUP] 4 [/SUP], Weimin Li[SUP] 5 [/SUP], Chengdi Wang[SUP] 6 [/SUP]
Affiliations
There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the growing population of recovered patients, it is crucial to understand the long-term consequences of the disease and management strategies. Although COVID-19 was initially considered an acute respiratory illness, recent evidence suggests that manifestations including but not limited to those of the cardiovascular, respiratory, neuropsychiatric, gastrointestinal, reproductive, and musculoskeletal systems may persist long after the acute phase. These persistent manifestations, also referred to as long COVID, could impact all patients with COVID-19 across the full spectrum of illness severity. Herein, we comprehensively review the current literature on long COVID, highlighting its epidemiological understanding, the impact of vaccinations, organ-specific sequelae, pathophysiological mechanisms, and multidisciplinary management strategies. In addition, the impact of psychological and psychosomatic factors is also underscored. Despite these crucial findings on long COVID, the current diagnostic and therapeutic strategies based on previous experience and pilot studies remain inadequate, and well-designed clinical trials should be prioritized to validate existing hypotheses. Thus, we propose the primary challenges concerning biological knowledge gaps and efficient remedies as well as discuss the corresponding recommendations.
. 2023 Nov 1;8(1):416.
doi: 10.1038/s41392-023-01640-z. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li[SUP] #[/SUP][SUP] 1 [/SUP], Yun Zhou[SUP] #[/SUP][SUP] 1 [/SUP], Jiechao Ma[SUP] #[/SUP][SUP] 2 [/SUP], Qin Zhang[SUP] #[/SUP][SUP] 1 3 [/SUP], Jun Shao[SUP] 1 [/SUP], Shufan Liang[SUP] 1 [/SUP], Yizhou Yu[SUP] 4 [/SUP], Weimin Li[SUP] 5 [/SUP], Chengdi Wang[SUP] 6 [/SUP]
Affiliations
- PMID: 37907497
- DOI: 10.1038/s41392-023-01640-z
There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the growing population of recovered patients, it is crucial to understand the long-term consequences of the disease and management strategies. Although COVID-19 was initially considered an acute respiratory illness, recent evidence suggests that manifestations including but not limited to those of the cardiovascular, respiratory, neuropsychiatric, gastrointestinal, reproductive, and musculoskeletal systems may persist long after the acute phase. These persistent manifestations, also referred to as long COVID, could impact all patients with COVID-19 across the full spectrum of illness severity. Herein, we comprehensively review the current literature on long COVID, highlighting its epidemiological understanding, the impact of vaccinations, organ-specific sequelae, pathophysiological mechanisms, and multidisciplinary management strategies. In addition, the impact of psychological and psychosomatic factors is also underscored. Despite these crucial findings on long COVID, the current diagnostic and therapeutic strategies based on previous experience and pilot studies remain inadequate, and well-designed clinical trials should be prioritized to validate existing hypotheses. Thus, we propose the primary challenges concerning biological knowledge gaps and efficient remedies as well as discuss the corresponding recommendations.